PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP

Detalles Bibliográficos
Autores principales: Festuccia, Moreno Benedetto, Evangelista, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428763/
http://dx.doi.org/10.1097/01.HS9.0000977024.02738.3a
_version_ 1785090547534266368
author Festuccia, Moreno Benedetto
Evangelista, Andrea
author_facet Festuccia, Moreno Benedetto
Evangelista, Andrea
author_sort Festuccia, Moreno Benedetto
collection PubMed
description
format Online
Article
Text
id pubmed-10428763
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104287632023-08-17 PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP Festuccia, Moreno Benedetto Evangelista, Andrea Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428763/ http://dx.doi.org/10.1097/01.HS9.0000977024.02738.3a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Festuccia, Moreno Benedetto
Evangelista, Andrea
PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP
title PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP
title_full PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP
title_fullStr PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP
title_full_unstemmed PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP
title_short PB2583: RUXOLITINIB IN SEVERE AND CRITICAL COVID19 REQUIRING CPAP
title_sort pb2583: ruxolitinib in severe and critical covid19 requiring cpap
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428763/
http://dx.doi.org/10.1097/01.HS9.0000977024.02738.3a
work_keys_str_mv AT festucciamorenobenedetto pb2583ruxolitinibinsevereandcriticalcovid19requiringcpap
AT evangelistaandrea pb2583ruxolitinibinsevereandcriticalcovid19requiringcpap

Ejemplares similares